Elscint Biomedical Investment

Venture Capital Active Israel
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$25.8M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Gamida Cell
Cellular and Immune Therapies
2 rounds $25.8M committed Latest: 2006-09

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Elscint Biomedical Investment's primary sector focus?
Elscint Biomedical Investment primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.
Can you name a notable exit for Elscint Biomedical Investment?
A notable exit for Elscint Biomedical Investment is Gamida Cell, which had a POEvent in October 2018 with a valuation of $210M and raised $50M in capital.
Which portfolio company has Elscint Biomedical Investment invested in?
Elscint Biomedical Investment has invested in Gamida Cell, a company focused on Cellular and Immune Therapies, founded in 1998.
What was Elscint Biomedical Investment's most recent investment activity?
Elscint Biomedical Investment's most recent recorded investment activity was in September 2006, which was a D Round.
What was Elscint Biomedical Investment's earliest recorded investment activity?
Elscint Biomedical Investment's earliest recorded investment activity was in October 2001, which was a B Round.